Developing new drugs to treat hearing disorders and serious diseases of the central nervous system

News & Events

Tweets

AutifonyLtd @AutifonyLtd
Autifony Therapeutics and Boehringer Ingelheim to collaborate on novel ion channel target with potential in multipl… https://t.co/KMvOWVf9o5
Autifony Therapeutics regains rights to clinical stage Kv3 programme https://t.co/rBHjjR7aC0
RT @singular_talent:Barbara Domayne-Hayman joined us on Careers in Discovery to talk startups, careers and more. Barbara's experience… https://t.co/u0VXnvXlGI
Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image